DIAGNOS Statistics
Total Valuation
DIAGNOS has a market cap or net worth of 19.14 million. The enterprise value is 19.75 million.
| Market Cap | 19.14M |
| Enterprise Value | 19.75M |
Important Dates
The last earnings date was Friday, August 22, 2025.
| Earnings Date | Aug 22, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 101.86M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +26.47% |
| Shares Change (QoQ) | +2.91% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 96.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 301.82 |
| PB Ratio | -32.57 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.75 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -7.10 |
Financial Position
The company has a current ratio of 0.73
| Current Ratio | 0.73 |
| Quick Ratio | 0.69 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.66 |
| Interest Coverage | -7.47 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -169.60% |
| Return on Invested Capital (ROIC) | -216.50% |
| Return on Capital Employed (ROCE) | 774.00% |
| Revenue Per Employee | 2,883 |
| Profits Per Employee | -156,077 |
| Employee Count | 22 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.53% in the last 52 weeks. The beta is -0.61, so DIAGNOS's price volatility has been lower than the market average.
| Beta (5Y) | -0.61 |
| 52-Week Price Change | -31.53% |
| 50-Day Moving Average | 0.16 |
| 200-Day Moving Average | 0.19 |
| Relative Strength Index (RSI) | 53.93 |
| Average Volume (20 Days) | 153,152 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DIAGNOS had revenue of 63,430 and -3.43 million in losses. Loss per share was -0.04.
| Revenue | 63,430 |
| Gross Profit | -899,563 |
| Operating Income | -3.14M |
| Pretax Income | -3.43M |
| Net Income | -3.43M |
| EBITDA | -3.13M |
| EBIT | -3.14M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 1.22 million in cash and 1.83 million in debt, giving a net cash position of -610,023.
| Cash & Cash Equivalents | 1.22M |
| Total Debt | 1.83M |
| Net Cash | -610,023 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -587,842 |
| Book Value Per Share | -0.01 |
| Working Capital | -508,779 |
Cash Flow
In the last 12 months, operating cash flow was -2.77 million and capital expenditures -12,942, giving a free cash flow of -2.78 million.
| Operating Cash Flow | -2.77M |
| Capital Expenditures | -12,942 |
| Free Cash Flow | -2.78M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -4,950.61% |
| Pretax Margin | -5,413.36% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DIAGNOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.47% |
| Shareholder Yield | n/a |
| Earnings Yield | -17.94% |
| FCF Yield | -14.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 24, 2019. It was a reverse split with a ratio of 0.1.
| Last Split Date | Apr 24, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
DIAGNOS has an Altman Z-Score of -39.51 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -39.51 |
| Piotroski F-Score | 3 |